Pfizer Has a $650 Million Plan in the Works

Pfizer plans to build a Manufacturing Technology Center of approximately 220,000 square feet at their research and development campus in Groton, Connecticut. The project is a $650 million capital investment spread over the next five years.

The new facility will produce clinical drug ingredients and drug products for Pfizer clinical trials around the world. Put simply, this is where the medicines being tested will get made.

Construction is planned to begin in the second quarter of 2027. Operations are targeted for the middle of 2031, which makes for a long runway from first shovel to opening day.

Senator-elect Joe de la Cruz (D-Groton) put the focus on the trades. “I spent my career in the trades, and I know what a project this size means: years of work for the carpenters, electricians, sheet metal workers, and laborers who will build it,” he said. “And when the construction crews leave, the jobs stay.”

Senate Majority Leader Bob Duff (D-Norwalk) spoke to the site choice. “Pfizer could have built this anywhere in the world, and it chose Groton,” he said.

On pharma jobs, the mechanical scope often sets the pace. Clinical manufacturing space usually calls for tight environmental controls, process piping, and heavy validation before anyone makes a single dose. That puts mechanical, sheet metal, and controls trades at the center of the schedule.

This one also goes up on a campus where Pfizer already has people at work. That usually means tight laydown space, strict access rules, and crews building around people who still have science to do. Teams with a clean plan for working next to active operations will stand out when packages hit the street.

🥾Want to advertise in TheJobWalk? Learn More🥾